Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

131
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
131
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

486
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
486
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the reproducibility of the social and behavioural sciences.

Nature·2026
Same author

Visual search of illusory contours: The role of illusory contour clarity.

Attention, perception & psychophysics·2024
Same author

Visual search of illusory contours: The role of illusory contour clarity.

Attention, perception & psychophysics·2023
Same author

Development of dynamic attention: Time-based visual selection for objects in motion between 6-12 years of age.

Developmental psychology·2022
Same author

The globalizability of temporal discounting.

Nature human behaviour·2022
Same author

Irrational beliefs differentially predict adherence to guidelines and pseudoscientific practices during the COVID-19 pandemic.

Applied cognitive psychology·2020

Related Experiment Video

Updated: Jul 12, 2025

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.9K

Cognitive performance outcomes: considerations for drug development.

Zorana Zupan1

  • 1Institute of Psychology, Faculty of Philosophy, University of Belgrade, Cika Ljubina 18/20, Belgrade, 11000, Serbia. zorana.zupan@f.bg.ac.rs.

Journal of Patient-Reported Outcomes
|October 19, 2023
PubMed
Summary

Validating cognitive performance outcome assessments (Cog-PerfOs) is crucial for evaluating new therapies. This involves enhancing content, ecological, and multinational construct validity for accurate efficacy measurement.

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.5K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.0K

Related Experiment Videos

Last Updated: Jul 12, 2025

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.9K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.5K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.0K

Area of Science:

  • Neuroscience
  • Clinical Psychology
  • Psychometrics

Background:

  • Clinical Outcome Assessments (COAs) are vital for therapeutic evaluation.
  • Cognitive performance outcome assessments (Cog-PerfOs) require specific validation considerations beyond general COA guidelines.

Purpose of the Study:

  • To identify critical areas for improving validation methods and best practices for Cog-PerfOs.
  • To address complexities in validating cognitive assessments for therapeutic efficacy.

Main Methods:

  • Review and discussion of validation methodologies for Cog-PerfOs.
  • Focus on content validity, ecological validity, and multinational construct validity.
  • Exploration of interdisciplinary approaches involving cognitive psychologists.

Main Results:

  • Content validity requires input from cognitive psychologists and congruence between lay and expert understanding.
  • Ecological validity needs to be demonstrated through robust evidence.
  • Multinational construct validity necessitates appropriate normative data.

Conclusions:

  • Improving Cog-PerfO validation involves cognitive psychologists, mixed-methods evidence, and multinational normative data.
  • Enhanced validation ensures Cog-PerfOs accurately reflect therapeutic effects on cognitive symptoms.
  • Standardized validation practices are essential for reliable evaluation of cognitive interventions.